Dr George Lee returns to discuss the latest medical news. Expect deep insights delivered with generous humour. Earlier this week, the Health Ministry announced  that it has approved the biosimilar version of trastuzumab, a targeted therapy for women with HER2-positive breast cancer. The biosimilar version will significantly reduce the cost of treatment, which currently costs RM130,000 a year. Datin Paduka Prof Dr Teo Soo Hwang, CEO of Cancer Research Malaysia, joins us to discuss how biosimilar therapies can improve accessibility to cancer care.

<p>Dr George Lee returns to discuss the latest medical news. Expect deep insights delivered with generous humour. Earlier this week, the Health Ministry <a href="https://www.thestar.com.my/news/nation/2018/12/10/patients-with-aggressive-type-of-breast-cancer-can-look-forward-to-cheaper-treatment/?fbclid=IwAR3pzm6HV-WJkYB2eq4FxRjWR4iQxCl92BRuQg9mLIs2jwWfVzGXI9G0BQg">announced </a>&nbsp;that it has approved the biosimilar version of trastuzumab, a targeted therapy for women with HER2-positive breast cancer. The biosimilar version will significantly reduce the cost of treatment, which currently costs RM130,000 a year. Datin Paduka Prof Dr Teo Soo Hwang, CEO of Cancer Research Malaysia, joins us to discuss how biosimilar therapies can improve accessibility to cancer care.</p>

Wander and be enlightened by the endlessly fascinating inner universe that is the human body. We speak with experts, Nobel laureates, cancer survivors and healthcare workers who share their unique perspectives on wellness and living and the latest medical research.

Health & Living

The Bigger Picture relishes its role as the heart and soul of the station. Tina Carmillia, Tee Shiao Eek, Sharmilla Ganesan, Lim Soon Heng and Juliet Jacobs delve into the human condition to find out what makes us tick. They speak with artists, environmentalists, medical experts, policy-makers and all manner of interesting people about the issues close to us, from education to refugee rights. Eclectic, energetic and a little eccentric, The Bigger Picture team brings you the latest thinking and research on that most fascinating subject: people.

Advertisement